EPS Creative Health Technology Group 3860.HK · HKD
Consumer Discretionary · HKEX · 🇭🇰 Hong Kong
0.59
-1.67%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in HKD, from our data supplier.
Revenue
HK$457.6m
FY2017FY2026
Net income
−HK$13.8m
FY2017FY2026
Free cash flow
HK$25.1m
FY2017FY2026
Shareholders' equity
HK$105.9m
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | HK$457.6m | HK$544.5m | HK$644.6m | HK$452.9m | HK$519.9m | HK$405.4m | HK$537.4m | HK$433.0m | HK$390.4m | HK$430.1m |
| Gross profit | HK$75.0m | HK$94.6m | HK$99.3m | HK$67.8m | HK$76.8m | HK$54.0m | HK$92.2m | HK$83.5m | HK$64.5m | HK$67.2m |
| Research and development | — | HK$18.1m | HK$24.3m | HK$13.0m | HK$11.2m | — | — | — | — | — |
| Operating income | HK$773,000 | HK$41.7m | −HK$17.0m | −HK$42.4m | −HK$14.4m | HK$7.3m | HK$33.1m | HK$32.8m | HK$20.0m | HK$11.9m |
| Net income | −HK$13.8m | HK$38.6m | −HK$22.1m | −HK$45.7m | −HK$22.6m | HK$6.5m | HK$22.7m | HK$27.2m | HK$14.1m | HK$6.1m |
| Diluted earnings per share | -0.03 | 0.07 | -0.04 | -0.09 | -0.05 | 0.01 | 0.05 | 0.05 | 0.03 | 0.01 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | HK$311.4m | HK$336.8m | HK$429.9m | HK$227.5m | HK$248.9m | HK$151.2m | HK$158.4m | HK$144.2m | HK$120.4m | HK$68.3m |
| Cash and short-term investments | HK$130.5m | HK$135.7m | HK$131.5m | HK$131.5m | HK$208.1m | HK$85.2m | HK$99.5m | HK$77.7m | HK$83.3m | HK$38.5m |
| Total liabilities | HK$158.7m | HK$174.3m | HK$291.7m | HK$135.8m | HK$122.2m | HK$18.0m | HK$31.8m | HK$32.3m | HK$28.1m | HK$42.9m |
| Debt | HK$4.5m | HK$57.2m | HK$11.5m | HK$73.6m | HK$9.1m | HK$2.4m | HK$3.2m | HK$262,000 | HK$384,000 | HK$20.8m |
| Shareholders' equity | HK$105.9m | HK$120.7m | HK$65.4m | HK$87.6m | HK$131.3m | HK$133.1m | HK$126.5m | HK$111.9m | HK$92.3m | HK$25.4m |
| Shares outstanding | 523m | 522m | 520m | 500m | 500m | 500m | 500m | 500m | 500m | 500m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | HK$28.2m | −HK$17.9m | −HK$28.6m | −HK$38.1m | HK$10.0m | −HK$12.4m | HK$24.6m | HK$4.2m | HK$23.4m | HK$16.0m |
| Capital spending | −HK$3.1m | −HK$5.7m | −HK$5.0m | −HK$2.4m | −HK$54,000 | −HK$525,000 | −HK$343,000 | −HK$2.9m | −HK$1.2m | −HK$326,000 |
| Free cash flow | HK$25.1m | −HK$23.6m | −HK$33.6m | −HK$40.5m | HK$10.0m | −HK$12.9m | HK$24.3m | HK$1.3m | HK$22.3m | HK$15.7m |
| Dividends paid | −HK$5.2m | — | — | — | — | — | −HK$8.0m | −HK$7.5m | −HK$7.5m | −HK$7.5m |
Latest quarters
By quarter end
| Mar 2026 | Sept 2025 | Mar 2025 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | HK$233.7m | HK$223.9m | HK$197.6m | HK$346.9m | HK$173.4m | HK$286.8m | HK$143.4m | HK$357.8m |
| Gross profit | HK$37.3m | HK$37.8m | HK$45.0m | HK$49.6m | HK$24.8m | HK$50.4m | HK$25.2m | HK$48.8m |
| Operating income | HK$1.4m | −HK$642,000 | HK$47.4m | −HK$5.7m | −HK$2.8m | −HK$17.0m | −HK$9.0m | −HK$20.2m |
| Net income | −HK$9.8m | −HK$4.1m | HK$23.9m | HK$14.7m | HK$7.3m | −HK$16.8m | −HK$8.4m | −HK$5.2m |
| Diluted earnings per share | -0.02 | -0.01 | 0.05 | 0.03 | 0.01 | -0.03 | -0.02 | -0.01 |
| Cash from operations | HK$7.0m | HK$16.0m | −HK$6.0m | −HK$11.0m | −HK$3.0m | −HK$33.0m | −HK$16.0m | HK$4.0m |
| Capital spending | −HK$1.0m | −HK$1.0m | −HK$4.0m | −HK$1.0m | — | −HK$3.0m | −HK$1.0m | −HK$1.0m |
| Free cash flow | HK$6.0m | HK$15.0m | −HK$10.0m | −HK$12.0m | — | −HK$36.0m | −HK$17.0m | HK$3.0m |
| Total assets | HK$311.4m | HK$351.5m | HK$336.8m | HK$474.9m | HK$474.9m | HK$429.9m | HK$429.9m | HK$374.9m |
| Cash and short-term investments | HK$130.5m | HK$118.9m | HK$135.7m | HK$102.3m | HK$102.3m | HK$131.5m | HK$131.5m | HK$132.5m |
| Debt | HK$2.7m | HK$3.4m | HK$6.7m | HK$52.9m | HK$51.9m | HK$9.9m | HK$134.0m | HK$8.6m |
| Shareholders' equity | HK$105.9m | HK$113.0m | HK$120.7m | HK$97.9m | HK$97.9m | HK$65.4m | HK$65.4m | HK$82.2m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.3% | 2.5% | 0.5% |
| Operating income | — | -36.1% | -27.5% |
| Net income | -32.8% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 16.9% | 16.0% | 15.5% | 16.0% |
| Operating margin | 4.2% | -0.8% | -0.8% | 1.8% |
| Net margin | 2.5% | -2.1% | -2.0% | 0.4% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -21.9 | 9.2 | -11.2 | -9.8 | -18.1 | 115.3 | 12.1 | 10.1 | 17.2 | 38.1 |
| Price to sales | 0.7 | 0.7 | 0.4 | 1.0 | 0.8 | 1.9 | 0.5 | 0.6 | 0.6 | 0.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 1 years. Last went ex-dividend on 20 Aug 2025.
| FY2026 | FY2020 | FY2019 | |
|---|---|---|---|
| Paid in the year | 0.01 | 0.016 | 0.015 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.